PlasmaTech Biopharmaceuticals (Nasdaq:PTBI) Soros Fund Confi
Post# of 58
Posted On: 05/05/2015 2:58:55 AM
Shares of PlasmaTech Biopharmaceuticals, Inc. (PTBI) soared more than 35% in the extended session Monday after one of the largest hedge fund firms in the world, Soros Fund Management LLC, disclosed in a regulatory filing with the Securities and Exchange Commission a 5.17% (or 1,166,667 shares) stake in the company.
The filing represents that billionaire investor George Soros' hedge fund has increased its ownership in PTBI by 366% from the 250,000 shares held at the end of the latest quarter ending Dec. 31, 2014.
PTBI is a biopharmaceutical company focused on advancing targeted treatments for significant unmet needs of critical patient care. Exploiting two distinct proprietary platforms, Salt Diafiltration (SDF(TM)) Process and Polymer Hydrogel Technology (PHT(TM)), PTBI is active in the development and commercialization of plasma-derived therapeutics and cancer supportive care products.
More about PlasmaTech Biopharmaceuticals, Inc. (PTBI) at www.plasmatechbio.com
**
The price of the stock of Nautilus Inc. (NLS) surged in after-hours trading Monday to reach a new 52-week high as the company delivered strong growth in its quarterly financial results, with profit and revenue numbers well above analysts' expectations.
For the first quarter 2015, NLS posted net sales of $96.2 million, a 34% increase year over year, and net income of $10.7 million, or $0.34 per diluted share, compared to net income of $5.4 million, or $0.17 per diluted share in the same quarter the prior year, surpassing the Capital IQ Consensus Estimate of $0.24 earnings per share on revenues of $83.54 million for the period.
NLS said that its improved financial performance and market success over the past few years has been driven by continued focus on product innovation, margin discipline, and realizing operating leverage.
NLS is a global fitness products company providing innovative, quality solutions to help people achieve a healthy lifestyle.
More about Nautilus Inc. (NLS) at www.nautilusinc.com
**
Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.
It has recently included the City of Perris, CA ( www.perris.crwe-pr.com ) into the CRWE Network.
Perris is located in Riverside County, California, 17.6 miles south of Riverside. It is a prominent regional distribution center.
The City of Perris had an estimated population in 2013 (U.S. Census Bureau) of 72,326, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally
The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
The filing represents that billionaire investor George Soros' hedge fund has increased its ownership in PTBI by 366% from the 250,000 shares held at the end of the latest quarter ending Dec. 31, 2014.
PTBI is a biopharmaceutical company focused on advancing targeted treatments for significant unmet needs of critical patient care. Exploiting two distinct proprietary platforms, Salt Diafiltration (SDF(TM)) Process and Polymer Hydrogel Technology (PHT(TM)), PTBI is active in the development and commercialization of plasma-derived therapeutics and cancer supportive care products.
More about PlasmaTech Biopharmaceuticals, Inc. (PTBI) at www.plasmatechbio.com
**
The price of the stock of Nautilus Inc. (NLS) surged in after-hours trading Monday to reach a new 52-week high as the company delivered strong growth in its quarterly financial results, with profit and revenue numbers well above analysts' expectations.
For the first quarter 2015, NLS posted net sales of $96.2 million, a 34% increase year over year, and net income of $10.7 million, or $0.34 per diluted share, compared to net income of $5.4 million, or $0.17 per diluted share in the same quarter the prior year, surpassing the Capital IQ Consensus Estimate of $0.24 earnings per share on revenues of $83.54 million for the period.
NLS said that its improved financial performance and market success over the past few years has been driven by continued focus on product innovation, margin discipline, and realizing operating leverage.
NLS is a global fitness products company providing innovative, quality solutions to help people achieve a healthy lifestyle.
More about Nautilus Inc. (NLS) at www.nautilusinc.com
**
Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.
It has recently included the City of Perris, CA ( www.perris.crwe-pr.com ) into the CRWE Network.
Perris is located in Riverside County, California, 17.6 miles south of Riverside. It is a prominent regional distribution center.
The City of Perris had an estimated population in 2013 (U.S. Census Bureau) of 72,326, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally
The CRWE Network has reached the 1487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
(0)
(0)Abeona Therapeutics Inc. (ABEO) Stock Research Links
Scroll down for more posts ▼